Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Breast Cancer Female × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Pain, Postoperative 5 Brain Neoplasms 5 Lung Neoplasms 3 Delirium 3 Uterine Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Kidney Neoplasms 2 Depression 2 Carcinoma, Non-Small-Cell Lung 2 Vomiting 1 Thromboembolism 1 Synovial Cyst 1 Surgical Wound Infection 1 Supratentorial Neoplasms 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Spondylosis 1 Spondylolisthesis 1 Spinal Stenosis 1 Sleep Initiation and Maintenance Disorders 1 Sleep Deprivation 1 Radiculopathy 1 Prostatic Neoplasms 1 Postoperative Hemorrhage 1 Pituitary Neoplasms 1 Pituitary Diseases 1 Otolaryngeal Cancer 1 Neuroinflammatory Diseases 1

Interventions

Sodium Chloride 1 Saline Solution 1 Ropivacaine 1 Passive Cutaneous Anaphylaxis 1 Metformin 1 Ketorolac Tromethamine 1 Bupivacaine 1 Atorvastatin 1 Analgesia, Patient-Controlled 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03007381 2017-08-16

KANGAROO

Nova Scotia Health Authority

Phase 4 Withdrawn

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡